Cardio Diabetes Master Class. Asian chapter

Held on April 20-21, 2013 Hanoi, Vietnam

Apr. 20, 2013

3rd Cardio Diabetes Master Class – Asian Chapter

Exploring new risk management strategies for Asia: Focus on Hypertension & Diabetes

TheCardio Diabetes Master Class was a dynamic meeting with state of the art lectures, clinical debates and practical workshops. Participants are part of an ongoing educational initiative that support clinicians in their daily clinical management of cardiovascular risk and diabetes. As an educational service teaching slides developed and presented by faculty are available to view and download for participants.

The educational objectives of the program were:

To summarise the epidemiology and pathophysiology of patients at increased cardiovascular risk and diabetes
To explore mechanisms and common pathways underlying the development of cardiovascular disease and diabetes
To review and discuss the importance of glucose management and the rationale for early intervention strategies in patients with diabetes
To discuss the role of anti-diabetic therapy, in particular the use of TZD’s, in a risk-based intervention strategy that targets glucose control and cardiovascular risk factors
To provide an expert perspective on the expanding role of RAS blockade in multiple organs in the treatment of patients at increased CV risk
To provide an expert perspective in the ongoing debate on the role of TZD’s in the treatment of patients with diabetes
To discuss current and future strategies for practical management and interventions to prevent cardiovascular events in multirisk patients

Webcasts

Watch short interviews with faculty members recorded during the Cardio Diabetes Master Class in Hanoi where they provide updates on recent developments

Webcast • CDMC Hanoi

Burden of CV disease in developing countries: Need for investment

Prof John Deanfield with a call for action to address the growing burden of CV disease in developing countries and the need or a coordinated effort to tackle this

Webcast • CDMC hanoi

HPS2-THRIVE and the future of clinical endpoint trials

Prof. John Betteridge with a critical appraisal of the results of the HPS2-THRIVE trial and the relevance for clinical practice and design of future outcome trials

Webcast • CDMC Hanoi

Preview on new hypertension guidelines

Prof Michael Weber provides his expectations on the right level of blood pressure targets, the elderly patients and optimal therapies

Webcast • CDMC Hanoi

Controversial issues in glycemic control

Prof. Mark Cooper, Melbourne, about the relationship between glucose control and cardiovascular outcomes and expected results of large trials with newer agents

Webcast • CDMC Hanoi

Prevalence of hypertension set to increase in Asia

Prof. Bernhard Cheung, Hong Kong emphasizes the need to look for undetected hypertension in Asia as the prevalence is expected to rise in the next decade